Form 4: Summit Partners Sells 3.8 Million Shares of LifeStance Health Group

Summit Partners Growth Equity Fund IX-A, L.P. and related entities sold 3,802,345 shares of LifeStance Health Group, Inc. at $5.89 per share on May 24, 2024.

Summary

• On May 24, 2024, Summit Partners Growth Equity Fund IX-A, L.P. and related entities disposed of 3,802,345 shares of LifeStance Health Group, Inc.
• The shares were sold at a price of $5.89 per share.
• Following the transaction, Summit Partners and related entities still beneficially own 41,932,358 shares of LifeStance Health Group, Inc.
• The reporting entities include Summit Partners Growth Equity Fund IX-A, L.P., Summit Partners Growth Equity Fund IX-B, L.P., Summit Investors GE IX/VC IV, LLC, Summit Partners Entrepreneur Advisors Fund II, L.P., and Summit Investors GE IX/VC IV (UK), L.P.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to a share sale. It doesn't inherently convey positive or negative sentiment, but rather reports a transaction. The sentiment is neutral.

Industry Context

This transaction reflects activity by a major shareholder in the healthcare services sector. Monitoring such transactions can provide insights into investor sentiment and potential future strategic moves within the industry.

Comparison to Industry Standards

• It's common for large shareholders like private equity funds to periodically adjust their holdings in publicly traded companies.
• Similar transactions can be observed with other healthcare companies where private equity firms have significant ownership positions.
• The impact of such sales on the stock price depends on various factors, including the size of the sale relative to the trading volume and overall market conditions.

Stakeholder Impact

• The sale of shares by a major shareholder like Summit Partners could potentially influence the market price of LifeStance Health Group, Inc.
• The transaction may be of interest to current and potential investors in the company.

Key Dates